Mesenchymal Stromal Cell Uses for Acute Kidney Injury—Current Available Data and Future Perspectives: A Mini-Review

by Shani Zilberman-Itskovich, Shani Zilberman-Itskovich, Shai Efrati, Shai Efrati
Published 2020-07-01

Effect of anti-C5 antibody on recuperation from ischemia/reperfusion-induced acute kidney injury

by Shani Zilberman-Itskovich, Ramzia Abu-Hamad, Moshe Stark, Shai Efrati
Published 2019-01-01

Prior ischemic strokes are non-inferior for predicting future ischemic strokes than CHA2DS2-VASc score in hemodialysis patients with non-valvular atrial fibrillation

by Anat Bel-Ange, Shani Zilberman Itskovich, Liana Avivi, Kobi Stav, Shai Efrati, Ilia Beberashvili
Published 2021-05-01

The impact of improper empirical usage of antipseudomonals on admission to an acute care hospital

by Nirit Kronenfeld, Shani Zilberman-Itskovich, Tsillia Lazarovitch, Ronit Zaidenstein, Hodaya Saadon, Tal Maya, David E. Katz, Dror Marchaim
Published 2020-09-01

Human mesenchymal stromal cells ameliorate complement induced inflammatory cascade and improve renal functions in a rat model of ischemia-reperfusion induced acute kidney injury.

by Shani Zilberman-Itskovich, Ramzia Abu-Hamad, Rina Zarura, Marina Sova, Yafit Hachmo, Moshe Stark, Sara Neuman, Shimon Slavin, Shai Efrati
Published 2019-01-01